
- 302 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
Implantable technologies allow for a sustained control over the release of pharmaceuticals into the bloodstream thereby achieving a controlled concentration with the potential to minimise side-effects while increasing patient compliance. Significant progress has been made in various alternative implantable delivery technologies, notably in intraocular and subcutaneous devices. Despite success in research and clinical studies, long-term clinical efficacy may be more limited and different aspects related to drug development and commercialization using these technologies are not well understood or practiced in the commercial setting. This book provides a comprehensive and cohesive picture of the latest in the field while also outlining the opportunities and challenges in implantable technology. Implantable Technologies: Pepties and Biologic Drug Development is an ideal reference for any postgraduate or researcher interested in utilising implantable technologies and novel routes of drug administration. The book will also be of interest to those involved in formulation and clinical application for a wide array of disease areas in addition to more established paradigms such as diabetes and pain management.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Half Title
- Series Title
- Title
- Copyright
- Foreword
- Preface
- Editor Biography
- Contents
- Chapter 1 Status of Implantable and Long-acting Injectable Technologies 1
- Chapter 2 Developing Complex Dosage Forms of Long-acting Biologics for the Eye: Current State, Challenges, and Opportunities 14
- Chapter 3 Monolithic Devices for Sustained Delivery of Protein Therapeutics for Ocular Disease 54
- Chapter 4 Sustained Delivery of Ocular Protein Therapeutics 76
- Chapter 5 Development of Risperidone Implant Formulations (DLP-114) for Long-term Maintenance Treatment of Schizophrenia 90
- Chapter 6 In-line Extrusion Process and Product Evaluation of ProNeura® by Near-infrared Spectroscopy 111
- Chapter 7 Addressing Immunogenicity for Implantable Drug-delivery Devices and Long-acting Injectables, Including Pharmacokinetic and Pharmacodynamic Correlations 131
- Chapter 8 Characterization Methods for Parenteral Peptide Controlled Release Drug Delivery Systems 160
- Chapter 9 Parenteral Delivery of Therapeutic Proteins, Peptides and Small Molecules Using Biodegradable Silica 188
- Chapter 10 Development of User-initiated Vaginal Dosage Forms 216
- Chapter 11 Three-dimensional Printed Implantable Products 252
- Subject Index